The respiratory tract microbiome and lung inflammation: A two-way street

Mucosal Immunology

Volumn 10, Issue 2, 2017, Pages 299-306

  Huffnagle, G B ^a   Dickson, R P ^a   Lukacs, N W ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL FLORA; CHRONIC INFLAMMATION; DISEASE COURSE; DISEASE MARKER; GAMMAPROTEOBACTERIA; HOMEOSTASIS; HUMAN; IMMUNITY; LOWER RESPIRATORY TRACT; MICROBIOME; MOUTH CAVITY; MOUTH FLORA; NASAL MICROBIOME; NONHUMAN; PATHOGENESIS; PNEUMONIA; PREVOTELLA; RESPIRATORY SYSTEM; REVIEW; SIGNAL TRANSDUCTION; UPPER RESPIRATORY TRACT; ANIMAL; CAPILLARY PERMEABILITY; DYSBIOSIS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; LUNG DISEASE; MICROBIOLOGY; MICROFLORA;

ANIMALS; CAPILLARY PERMEABILITY; DYSBIOSIS; GAMMAPROTEOBACTERIA; HOMEOSTASIS; HOST-PATHOGEN INTERACTIONS; HUMANS; LUNG DISEASES; MICROBIOTA; PNEUMONIA; PREVOTELLA; RESPIRATORY SYSTEM;

EID: 85014537638     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2016.108     Document Type: Review

References (73)

1. Dickson, R.P., Erb-Downward, J.R., Martinez, F.J. & Huffnagle, G.B. The microbiome and the respiratory tract. Annu. Rev. Physiol. 78, 481-504 (2016).
2. Horikoshi, K. & Grant, W.D. Extremophiles: Microbial Life In Extreme Environments, Vol 20 (Wiley-Liss, 1998).
3. Gleeson, K., Eggli, D.F. &Maxwell, S.L. Quantitative aspiration during sleep in normal subjects. Chest 111, 1266-1272 (1997).
4. Huxley, E.J., Viroslav, J., Gray, W.R. & Pierce, A.K. Pharyngeal aspiration in normal adults and patients with depressed consciousness. Am. J. Med. 64, 564-568 (1978).
5. Quinn, L.H. & Meyer, O.O. The relationship of sinusitis and bronchiectasis. Arch. Otolaryngol.-Head Neck Surg. 10, 152 (1929).
6. Amberson, J.B. A clinical consideration of abscesses and cavities of the lung. Bull. Johns Hopkins Hosp. 94, 227-237 (1954).
7. Hilty, M. et al. Disordered microbial communities in asthmatic airways. PLOS One 5, e8578 (2010).
8. Dickson, R.P. & Huffnagle, G.B. The lung microbiome: new principles for respiratory bacteriology in health and disease. PLOS. Pathog. 11, e1004923 (2015).
9. Dickson, R.P., Erb-Downward, J.R. & Huffnagle, G.B. Towards an ecology of the lung: new conceptual models of pulmonary microbiology and pneumonia pathogenesis. Lancet Resp. Med. 2, 238-246 (2014).
10. Grice, E.A. et al. Topographical and temporal diversity of the human skin microbiome. Science 324, 1190-1192 (2009).
11. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 486, 207-214 (2012).
12. Charlson, E.S. et al. Disordered microbial communities in the upper respiratory tract of cigarette smokers. PLoS One 5, e15216 (2010).
13. Rasmussen, T.T., Kirkeby, L.P., Poulsen, K., Reinholdt, J. & Kilian, M. Resident aerobic microbiota of the adult human nasal cavity. APMIS 108, 663-675 (2000).
14. Bassis, C.M. et al. Analysis of the upper respiratory tractmicrobiotas as the source of the lung and gastric microbiotas in healthy individuals. MBio 6, e00037 (2015).
15. Lam, K., Schleimer, R. & Kern, R.C. The etiology and pathogenesis of chronic rhinosinusitis: A review of current hypotheses. Curr. Allergy. Asthma. Rep. 15, 41 (2015).
16. Whelan, F.J. et al. The loss of topography in the microbial communities of the upper respiratory tract in the elderly. Ann. Am. Thorac Soc. 11, 513-521 (2014).
17. Bisgaard, H. et al. Childhood asthma after bacterial colonization of the airway in neonates. N. Engl. J. Med. 357, 1487-1495 (2007).
18. Dewhirst, F.E. et al. The human oral microbiome. J. Bacteriol. 192, 5002-5017 (2010).
19. Morris, A. et al. Comparison of the respiratory microbiome in healthy nonsmokers and smokers. Am. J. Respir.Crit. Care. Med. 187, 1067-1075 (2013).
20. Dickson, R.P. et al. Spatial variation in the healthy human lung microbiome and the adapted island model of lung biogeography. Ann. Am. Thorac Soc. 12, 821-830 (2015).
21. Rivera-Chavez, F. et al. Salmonella uses energy taxis to benefit from intestinal inflammation. PLOS Pathog. 9, e1003267 (2013).
22. Winter, S.E. et al. Host-derived nitrate boosts growth of E. coli in the inflamed gut. Science 339, 708-711 (2013).
23. Dickson, R.P., Erb-Downward, J.R. & Huffnagle, G.B. The role of the bacterial microbiome in lung disease. Expert Rev. Respir. Med. 7, 245-257 (2013).
24. Bartemes, K.R. & Kita, H. Dynamic role of epithelium-derived cytokines in asthma. Clin. Immunol. 143, 222-235 (2012).
25. Scanlon, S.T.&McKenzie, A.N. Type 2 innate lymphoid cells: new players in asthma and allergy. Curr. Opin. Immunol. 24, 707-712 (2012).
26. Lai, H.Y. & Rogers, D.F. Mucus hypersecretion in asthma: intracellular signalling pathways as targets for pharmacotherapy. Curr. Opin. Allergy Clin. Immunol. 10, 67-76 (2010).
27. Flierl, M.A. et al. Phagocyte-derived catecholamines enhance acute inflammatory injury. Nature 449, 721-725 (2007).
28. Sperandio, V., Torres, A.G., Jarvis, B., Nataro, J.P. & Kaper, J.B. Bacteriahost communication: The language of hormones. Proc. Natl Acad. Sci. USA 100, 8951-8956 (2003).
29. Venkataraman, A. et al. Application of a neutral community model to assess structuring of the human lung microbiome. MBio 6, e02284-14 (2015).
30. Segal, L.N. et al. Enrichment of lung microbiome with supraglottic taxa is associated with increased pulmonary inflammation. Microbiome 1, 19 (2013).
31. Rogers, G.B. et al. A novel microbiota stratification system predicts future exacerbations in bronchiectasis. Ann. Am. Thorac Soc. 11, 496-503 (2014).
32. Molyneaux, P.L. et al. The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care. Med. 190, 906-913 (2014).
33. Huang, Y.J. et al. Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J. AllergyClin. Immunol. 127, 372-381 e371-373 (2011).
34. Goleva, E. et al. The effects of airway microbiome on corticosteroid responsiveness in asthma. Am. J. Respir.Crit. Care. Med. 188, 1193-1201 (2013).
35. Koh, T.J. & DiPietro, L.A. Inflammation and wound healing: The role of the macrophage. Expert Rev. Mol. Med. 13, e23 (2011).
36. Winter, S.E. & Baumler, A.J. Why related bacterial species bloom simultaneously in the gut: principles underlying the Like will to like concept. Cell. Microbiol. 16, 179-184 (2014).
37. Winter, S.E. & Baumler, A.J. Dysbiosis in the inflamed intestine: chance favors the prepared microbe. Gut Microbes 5, 71-73 (2014).
38. Scales, B.S., Dickson, R.P. & Huffnagle, G.B. A tale of two sites: how inflammation can reshape the microbiomes of the gut and lungs. J. Leuk. Biol. 100, 943-950 (2016).
39. Bogdan, C. Nitric oxide synthase in innate and adaptive immunity: An update. Trends Immunol. 36, 161-178 (2015).
40. Lopez, C.A., Rivera-Chavez, F., Byndloss, M.X. & Baumler, A.J. The periplasmic nitrate reductase NapABC supports luminal growth of Salmonella enterica serovar typhimurium during colitis. Infect. Immun. 83, 3470-3478 (2015).
41. Bliska, J.B. & van der Velden, A.W. Salmonella "sops" up a preferred electron receptor in the inflamed intestine. MBio 3, e00226-00212 (2012).
42. Lopez, C.A. et al. Phage-mediated acquisition of a type III secreted effector protein boosts growth of salmonella by nitrate respiration. MBio 3, e00143-12 (2012).
43. Vazquez-Torres, A. & Baumler, A.J. Nitrate, nitrite and nitric oxide reductases: from the last universal common ancestor to modern bacterial pathogens. Curr. Opin. Microbiol. 29, 1-8 (2015).
44. Spees, A.M. et al. Streptomycin-induced inflammation enhances Escherichia coli gut colonization through nitrate respiration. mBio 4, e00430-13 (2013).
45. Sabra, W., Kim, E.J. & Zeng, A.P. Physiological responses of Pseudomonas aeruginosa PAO1 to oxidative stress in controlled microaerobic and aerobic cultures. Microbiology 148, 3195-3202 (2002).
46. Bernasconi, E. et al. Airway microbiota determines innate cell inflammatory or tissue remodeling profiles in lung transplantation. Am. J. Respir. Crit. Care. Med. 194, 1252-1263 (2016).
47. Larsen, J.M., Musavian, H.S., Butt, T.M., Ingvorsen, C., Thysen, A.H. & Brix, S. Chronic obstructive pulmonary disease and asthma-Associated Proteobacteria, but not commensal Prevotella spp., promote Toll-like receptor 2-independent lung inflammation and pathology. Immunology 144, 333-342 (2015).
48. Brix, S., Eriksen, C., Larsen, J.M. & Bisgaard, H. Metagenomic heterogeneity explains dual immune effects of endotoxins. J. Allergy Clin. Immunol. 135, 277-280 (2015).
49. Larsen, J.M. et al. Divergent pro-inflammatory profile of human dendritic cells in response to commensal and pathogenic bacteria associated with the airway microbiota. PLOS ONE 7, e31976 (2012).
50. Hemmi, H. et al. AToll-like receptor recognizes bacterial DNA. Nature 408, 740-745 (2000).
51. Honko, A.N. & Mizel, S.B. Effects of flagellin on innate and adaptive immunity. Immunol. Res. 33, 83-101 (2005).
52. Segal, L.N. et al. Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype. Nat. Microbiol. 1, 16031 (2016).
53. Tunney, M.M. et al. Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. Am. J. Respir. Crit. Care. Med. 177, 995-1001 (2008).
54. Yadava, K. et al. Microbiota promotes chronic pulmonary inflammation by enhancing IL-17A and autoantibodies. Am. J. Respir. Crit. CareMed. 193, 975-987 (2016).
55. Richmond, B.W. et al. Airway bacteria drive a progressive COPD-like phenotype in mice with polymeric immunoglobulin receptor deficiency. Nat. Commun. 7, 11240 (2016).
56. Herbst, T. et al. Dysregulation of allergic airway inflammation in the absence of microbial colonization. Am. J. Respir. Crit. Care Med. 184, 198-205 (2011).
57. Noverr, M.C., Falkowski, N.R., McDonald, R.A., McKenzie, A.N. & Huffnagle, G.B. Development of allergic airway disease in mice following antibiotic therapy and fungal microbiota increase: role of host genetics, antigen, and interleukin-13. Infect. Immun. 73, 30-38 (2005).
58. Noverr, M.C., Noggle, R.M., Toews, G.B. & Huffnagle, G.B. Role of antibiotics and fungal microbiota in driving pulmonary allergic responses. Infect. Immun. 72, 4996-5003 (2004).
59. Trompette, A. et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat. Med. 20, 159-166 (2014).
60. Fujimura, K.E. et al. House dust exposure mediates gut microbiome Lactobacillus enrichment and airway immune defense against allergens and virus infection. Proc. Natl Acad. Sci. USA 111, 805-810 (2014).
61. Atarashi, K. et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331, 337-341 (2011).
62. Zeng, H. & Chi, H. Metabolic control of regulatory T cell development and function. Trends Immunol. 36, 3-12 (2015).
63. Kosiewicz, M.M., Dryden, G.W., Chhabra, A. & Alard, P. Relationship between gut microbiota and development of T cell associated disease. FEBS Lett. 588, 4195-4206 (2014).
64. Geuking, M.B., McCoy, K.D. & Macpherson, A.J. Metabolites from intestinal microbes shape Treg. Cell. Res. 23, 1339-1340 (2013).
65. Arpaia, N. et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504, 451-455 (2013).
66. Memari, B. et al. Engagement of the aryl hydrocarbon receptor in mycobacterium tuberculosis-infected macrophages has pleiotropic effects on innate immune signaling. J. Immunol. 195, 4479-4491 (2015).
67. Zelante, T. et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 39, 372-385 (2013).
68. Freestone, P.P. et al. Pseudomonas aeruginosa-catecholamine inotrope interactions: A contributory factor in the development of ventilatorassociated pneumonia?. Chest 142, 1200-1210 (2012).
69. Kanangat, S. et al. Effects of cytokines and endotoxin on the intracellular growth of bacteria. Infect. Immun. 67, 2834-2840 (1999).
70. Kaza, S.K., McClean, S. & Callaghan, M. IL-8 released from human lung epithelial cells induced by cystic fibrosis pathogens Burkholderia cepacia complex affects the growth and intracellular survival of bacteria. Int. J. Med. Microbiol. 301, 26-33 (2011).
71. Porat, R., Clark, B.D., Wolff, S.M. & Dinarello, C.A. Enhancement of growth of virulent strains of Escherichia coli by interleukin-1. Science 254, 430-432 (1991).
72. Marks, L.R., Davidson, B.A., Knight, P.R. & Hakansson, A.P. Interkingdom signaling induces Streptococcus pneumoniae biofilm dispersion and transition from asymptomatic colonization to disease. MBio 4, e00438-13 (2013).
73. Schmidt, A. et al. Neutrophil elastase-mediated increase in airway temperature during inflammation. J. Cyst. Fibros. 13, 623-631 (2014).